Company Warned for Noncompliance on Clinical Trial Protocol, Protections

Devices & Diagnostics Letter
The FDA handed Atlanta-based CardioMEMS a warning letter for numerous deviations related to a clinical investigation and PMA for its CardioMEMS HF Pressure Measurement System.

To View This Article:


Subscribe To Devices & Diagnostics Letter

Buy This Article Now

Add this article to your cart for $25.00